Cencora, Inc. Common Stock

Afficher le graphique complet Full chart

Financials

Total de l'actif 44.27 B57.34 B56.56 B62.56 B67.1 B76.59 B Total du passif 45.5 B57.7 B57.35 B62.82 B67.34 B76.26 B Total des capitaux propres -839.64 M584.41 M71.27 M666.29 M786.74 M1.75 B Total du passif et des capitaux propres 44.27 B57.34 B56.56 B62.56 B67.1 B76.59 B Dette totale 4.12 B6.68 B5.7 B4.79 B4.39 B7.66 B Dette nette 4.12 B6.68 B5.7 B4.79 B4.39 B3.3 B

Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment.

COR

Financials

Cencora, Inc. Common Stock

Nouvelles

CAH vs. COR: Which Healthcare Distributor Stock Is the Better Buy?

Si vous aviez investi 100 $ dans l'action Cencora il y a 10 ans, vous auriez autant aujourd'hui | Benzinga France

Dividend Champion, Contender, And Challenger Highlights: Week Of May 24

S&P 500 Top Stock Gainers Today, 5/22/26 - TipRanks.com

CAH Stock Down Nearly 9.4% YTD: Should You Buy, Hold or Sell?

Are Wall Street Analysts Bullish on Cencora Stock?

Can CAH Sustain Growth on Booming Pharmaceutical & Specialty Segment?

Why Cencora (COR) is a Top Growth Stock for the Long-Term

TD Cowen maintient sa recommandation d’achat sur Cencora grâce aux génériques

Cencora (COR) is a Top-Ranked Value Stock: Should You Buy?

Dividend Champion, Contender, And Challenger Highlights: Week Of May 10

Stock Surge on Robust Tech Earnings and US-Iran Peace Hopes